Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Mar;4(3):384–395. doi: 10.1158/1940-6207.CAPR-10-0296

Table 1.

Ratio of amounts of SFT (SFR Treatment / GRR Treatment ratio of within-individual medians) and ratio of within-individual variability (coefficient of variation). Wilcoxon Signed-rank test for significancea.

Treatment arm Median of ratios of within-individual 7-day median SFT SFR Treated/GRR Treated [IQR] Median of ratios of within-individual 7-day coefficients of variation of SFT SFR Treated/GRR Treated[IQR]
SFR → GRR(n=23) 3.36 [2.05, 5.50]
p< 0.001
0.83 [0.34, 1.00]
p= 0.004
GRR → SFR (n=24) 3.59 [1.80, 7.93]
p< 0.001
0.54 [0.28, 0.78]
p< 0.001
Overall (n=47) 3.58 [2.02, 7.43]
p< 0.001
0.61 [0.33, 0.92]
p< 0.001
a

p-values for null hypothesis of median ratios being equal to 1.